Fulgent Genetics, Inc.
FLGT
$28.48
$0.080.28%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.77% | 11.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.77% | 11.35% | |||
| Cost of Revenue | 2.51% | 4.99% | |||
| Gross Profit | 3.13% | 21.48% | |||
| SG&A Expenses | -9.57% | 14.58% | |||
| Depreciation & Amortization | 1.76% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.07% | 8.86% | |||
| Operating Income | 22.13% | 0.41% | |||
| Income Before Tax | 65.11% | -83.56% | |||
| Income Tax Expenses | 69.82% | -1,385.80% | |||
| Earnings from Continuing Operations | 64.55% | -61.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -27.09% | -18.97% | |||
| Net Income | 65.14% | -64.41% | |||
| EBIT | 22.13% | 0.41% | |||
| EBITDA | 31.83% | 1.56% | |||
| EPS Basic | 65.37% | -65.94% | |||
| Normalized Basic EPS | 36.02% | -0.75% | |||
| EPS Diluted | 65.37% | -65.94% | |||
| Normalized Diluted EPS | 36.02% | -0.75% | |||
| Average Basic Shares Outstanding | 0.67% | -0.93% | |||
| Average Diluted Shares Outstanding | 0.67% | -0.93% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||